Controverse en tolerantie bij toepassing van β₂-agonisten per inhalatie

Farmacotherapie
Published: 01 February 1998

Volume 36, pages 30–31, (1998)
Cite this article

Medisch Farmaceutische Mededelingen

17 Accesses
Explore all metrics

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

Chapman KR et al. Lancet 1994; 343: 1379-82.
Article CAS Google Scholar
Cockcroft DW et al. Thorax 1996; 51: 1051-6.
Article CAS Google Scholar
Drazen JM et al. N Engl J Med 1996; 335: 841-7.
Article CAS Google Scholar
Schayk CP van et al. BMJ 1991; 303: 1426-31.
Article Google Scholar
Sears MR et al. Lancet 1990; 336: 1391-6.
Article CAS Google Scholar
Editorial. N Engl J Med 1996; 12: 886-8.

Download references

Verkrijgbaar

Salbutamol: in Nederland als zodanig en als Aerolin ^® en Ventolin ^®.

Salmeterol: in Nederland Serevent ^®.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Controverse en tolerantie bij toepassing van β₂-agonisten per inhalatie. MFAM 36, 30–31 (1998). https://doi.org/10.1007/BF03057082

Download citation

Published: 01 February 1998
Issue Date: February 1998
DOI: https://doi.org/10.1007/BF03057082

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions